The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
about
Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and diseaseGuidelines for Dual Energy X-Ray Absorptiometry Analysis of Trabecular Bone-Rich Regions in Mice: Improved Precision, Accuracy, and Sensitivity for Assessing Longitudinal Bone ChangesCultured human periosteal-derived cells have inducible adipogenic activity and can also differentiate into osteoblasts in a perioxisome proliferator-activated receptor-mediated fashion.Skeletal effects of the saturated 3-thia Fatty Acid tetradecylthioacetic Acid in rats.The role of homocysteine in bone remodelingNuclear hormone receptors as mediators of metabolic adaptability following reproductive perturbations.Intensive glycemic control and thiazolidinedione use: effects on cortical and trabecular bone at the radius and tibia.The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wastingTargeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in ObesityExamining the safety of PPAR agonists - current trends and future prospects.An energetic orphan in an endocrine tissue: a revised perspective of the function of estrogen receptor-related receptor alpha in bone and cartilage.The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Homocysteine as a Pathological Biomarker for Bone Disease.Genetic Susceptibility Contributing to Periodontal and Cardiovascular Disease.Peroxisome Proliferator-Activated Receptor α Facilitates Osteogenic Differentiation in MC3T3-E1 Cells via the Sirtuin 1-Dependent Signaling Pathway.MK886 inhibits the pioglitazone-induced anti-invasion of MDA-MB-231 cells is associated with PPARα/γ, FGF4 and 5LOX.Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats.Fenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model.Plasma choline, nicotine exposure, and risk of low bone mineral density and hip fracture: the Hordaland health study.PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity.Treatment of erosive osteoarthritis with peroxisome proliferator-activated receptor alpha agonist fenofibrate: a pilot study.Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.Adiponectin Reduces Bone Stiffness: Verified in a Three-Dimensional Artificial Human Bone Model In Vitro.Roles of the Chr.9p21.3 ANRIL Locus in Regulating Inflammation and Implications for Anti-Inflammatory Drug Target Identification.
P2860
Q28606560-577A7291-8FC4-4650-BE03-5BEBAE4EF491Q30758560-ED1D689A-8EFD-46D7-82BA-B15F4EB1F5D1Q34102038-340B2457-DFE9-4704-8F68-C085005B6352Q34108417-CC6FEA00-A2C8-4B21-9413-00724686F958Q34330278-3140AB87-595C-4844-A60A-E04024CBDE28Q36722812-21FCF6E9-5047-476C-80FD-10ABC87E428AQ36807306-986EC32E-F58E-47BD-ACD9-E7B91A3F301DQ36901945-05F40E59-621B-43F3-A4FD-F4270667187FQ37435676-1082881B-2C7F-437A-8AF5-8E2C60C51A28Q38058381-52B45752-AEFC-473C-84A8-58A88307E254Q38065111-C7E9A188-9DA6-4C49-9E10-6BCDD2434BEBQ38537377-CCC3200D-9E67-43CA-98BF-827C9D5CBFE7Q38641190-95EB3D3A-2CA0-4C36-856A-066FA3A3DBA0Q39012193-EDE1C0EB-8816-473F-AD87-97573EC0C032Q39321971-31869D97-E850-4B61-A5FA-D585C175677FQ41098162-60EF8D19-6ABB-47A7-9834-F2AFABB3F258Q41639652-5D9FE6F1-3A80-4A53-AEDB-E4B791A63F23Q41656785-78271E62-0844-40A6-883D-7BA5D19AB02AQ42377473-0D566BE8-C646-40A4-9118-27F58FF251B2Q44354378-D96F0E33-932D-47B5-98DA-58C7D675AD69Q44675066-30C02890-AFFC-485E-9910-1C111AE72F1AQ46009858-0DAA7678-CE6A-40EF-980C-7A98A7A76368Q46063885-F227B14E-2AFD-4AAD-93B3-45B287887A14Q55021030-E2A50453-22C8-4771-A544-CE53F58C7C07Q55078607-EBEDA276-6E9C-4A37-A208-B02EE845550C
P2860
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The peroxisome proliferator-ac ...... e loss, in ovariectomized rats
@ast
The peroxisome proliferator-ac ...... e loss, in ovariectomized rats
@en
type
label
The peroxisome proliferator-ac ...... e loss, in ovariectomized rats
@ast
The peroxisome proliferator-ac ...... e loss, in ovariectomized rats
@en
prefLabel
The peroxisome proliferator-ac ...... e loss, in ovariectomized rats
@ast
The peroxisome proliferator-ac ...... e loss, in ovariectomized rats
@en
P2093
P2860
P356
P1476
The peroxisome proliferator-ac ...... e loss, in ovariectomized rats
@en
P2093
Björn I Gustafsson
Christiane Petzold
Erik F Eriksen
Irene Westbroek
Jan H Waarsing
Janne E Reseland
Reidar Fossmark
Unni Syversen
P2860
P2888
P356
10.1186/1472-6823-11-11
P577
2011-05-26T00:00:00Z